drugset / Trial / NCT06025786

Impact Evaluation of Benazir Nashonuma Program (BNP) on Stunting Among Under-five Children

NCT06025786 ↗

Non-randomizedParallel-groupOpen-labelPrevention

Summary

The aim of the study is to evaluate the impact of Benazir Nashonuma Program (BNP) on prevalence of stunting among under-five children in low income setting of Pakistan. The research question that the study aims to answer is: Is there any change in the prevalence of stunting among under-five children in districts where Benazir Nashonuma Program (BNP) is established compared to districts where BNP is not established? Districts where BNP is functional, and women and children are receiving the intervention will be compared at baseline and end line with control districts where conventional reproductive care services are given. Prevalence of stunting among under-five children will be compared along with other nutritional and growth status indicators over a period of 4 years.

Timeline

Start
2021-12-01
Primary completion
2025-12-20
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Maamta Other / unclassified 75 g —
Subject Wawamum Other / unclassified — —